Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOPE-KIDS: Voxelotor in Pediatric Sickle Cell Disease
NCT02850406Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jul 2016
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of voxelotor in sickle cell disease (SCD), sponsored by Pfizer. Started Jul 2016; status: terminated.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02850406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02850406.